EQRx, Inc. logo

EQRx, Inc.

NASDAQ:EQRX

Overview | Financials
Company Name EQRx, Inc.
Symbol EQRX
Currency USD
Price 2.34
Market Cap 1,140,551,119
Dividend Yield 0%
52-week-range 1.58 - 4.75
Industry Biotechnology
Sector Healthcare
CEO Ms. Melanie I. Nallicheri
Website https://www.eqrx.com

An error occurred while fetching data.

About EQRx, Inc.

EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EGFR-mutated non-small cell lung

Related Stocks

Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

IOVA

7.96 USD

Insmed Incorporated logo

Insmed Incorporated

INSM

75.97 USD

OPKO Health, Inc. logo

OPKO Health, Inc.

OPK

1.49 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

25.94 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

32.63 USD

Axonics, Inc. logo

Axonics, Inc.

AXNX

67.72 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.79 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

28.52 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

33.88 USD

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.97 USD

Financials

Numbers are in millions USD

Numbers are in millions USD